Excessive activation of the hepatocyte growth factor/scatter factor (HGF/SF)-MET axis is considered to correlate with poor prognosis and drug resistance in various human cancers, including GC [1, 2, 7, 8]. This evidence concerns the gene MET and gastric cancer.